"Academic to Industry Translation in Cell Therapies: The Evolution of Concepts into Practice"
Abstract Submission Deadline: June 7th
September 8-11, 2013
For more information, CLICK HERE.
As Executive Director, I am pleased to announce staffing changes for the Head Office Team. Since assuming the Executive Director role for the Society, my focus has been on raising the Society’s international profile as a recognized leader in cell therapy translation through global branding of ISCT’s three pillars (Academia, Regulatory and Commercialization) and demonstrating the Society’s value proposition. READ MORE
The 12th Cell Therapy Liaison Meeting was held on November 19, 2012 in Bethesda, MD. The final summary and presentations are now available in the member resources webpage. CLICK HERE for access.
Join us for ISCT's first Satellite Global Regulatory Perspectives Workshop on January 27, 2013 in Washington, D.C.
Held on the Pre-Conference Day at the Phacilitate Cell & Gene Therapy Forum
Program and online registration now available.
Kurt Gunter, MD, FASCP
Cell Therapy 2012
Massimo Dominici, MD
1st ISCT Latin American Regional Meeting
Dominic Wall, PhD
"Challenge and Promise in Cell & Vaccine Therapy in Asia- Toward Clinical Approval for Commercialization"
1st National Stem Cell Congress
17th NSW Stem Cell Network- Cellular Therapies for Repair of Musculoskeletal Injuries
Pre-registration for the meeting has now closed. Visit the Sheraton Seattle at 4pm on June 4th to register on site.
Click Here for full conference information.
This year's program features a blend of presentations with interactive, parallel breakout sessions.
CLICK HERE to learn more. Space is limited so register early!
Updated program now available!
The objective of this workshop is to provide participants with viewpoints and perspectives from international regulators of cell therapy products, and to discuss current questions and regulatory controversies with regulators and industry representatives.
CLICK HERE for more information
- Labeling of Cellular Therapy Products version 1.0.0
- Use of the Product Code Data Structure  and Supporting Database for Cellular Therapy version 1.0.0
Comments due by January 31, 2012
The interest of many insured US citizens was represented by participation of payor organizations including Anthem Blue Cross Blue Shield, LifeTrac and OptumHealth.
CLICK HERE for full press release.
- Quality Assurance Manager
- Medical Technologist - Clinical Cell Processing Lab
- Cell Processing Technologist II
- Laboratory Supervisor/Program Manager
- Clinical Lab Scientist - Blood and Marrow Transplant Lab
Visit our careers page to learn more
- Report from PACT: Pluripotent Stem Cell Production
- FDA Proposes Significant Change to Rules for Microbiological Testing of Biological Products
- USP collaborative study for IL4 Reference Standard
CLICK HERE for access
October 3-5, 2011
ISCT members are eligible for $200 off corporate registrations and $150 off not-for-profit registrations. Codes expire on October 2nd at 12:00am.
The Ask the Expert Session will provide an opportunity for attendees to pose questions and solicit input from experts in the areas of cellular therapy collection and processing quality assurance, regulations, accreditation and compliance.
For those attending the meeting, please submit your question(s) in advance HERE.
For program and registration information, CLICK HERE.
Placental Derived Mesenchymal Cells, Isolation, Processing and Characterization
12pm - 1pm ET
CLICK HERE for speaker information, learning objectives, and registration information.
BMCOGS & Reimbursement Roundtable
"Achieving Reimbursement for Regenerative Medicine: Building Collaboration with Payors"
September 14, 2011: 8am - 1pm
CLICK HERE for program information and Industry participation opportunities.
ISCT is proud to annouce sponsorship and co-promotion of five sessions at the IBC Cell Therapy Bioprocessing Conference including a keynote address by ISCT President Elect Kurt Gunter.
ISCT Members receive 25% off registration for the conference.
CLICK HERE for more information.
The Cellular Therapy Coding and Labeling Advisory Group, formed in 2005, has worked to educate the CT community about and promote the adoption of ISBT 128 Coding and Labeling for CT products. While this global initiative continues to grow, having confirmation of ongoing support, through the Second Consensus Statement, by the participating organizational boards provides additional encouragement for Cellular Therapy facilities to move forward with implementation.
CLICK HERE to view the statement.
ISCT is pleased to announce the upcoming ISCT North American Regional Meeting from September 15-16, 2011 in Charlottsville, Virginia, USA.
This meeting is co-sponsored by ISCT and the Univerity of Virginia Health System. More information will be available soon.
Chair: Sara Murray, BS, DAS, Manager, Hematopoietic Cell Processing Laboratory, Knight Cancer Institute, Oregon Health & Science University
Speakers: William E. Janssen, PhD, Laboratory Director, Stem Cell Processing & Evaluation Laboratory, H. Lee Moffitt Cancer Center & Research Institute; Darin Sumstad, MT (ASCP), Clinical Laboratory Scientist - Technical Lead, Cell Therapy Clinical Laboratory, University of Minnesota Medical Center
Early Registration Deadline: April 6
Last Call for Exhibitors!
Only 2 spaces remain. Book your space today.
Gala Event Registration Open
Don't miss this special event on May 20th. The gala event will start with a reception at City Hall Rotterdam followed by dinner and live entertainment on board the SS Rotterdam. Transportation from City Hall to the SS Rotterdam, and return to the conference hotels included.
The 10th CTLM focused on Unrelated Allogeneic Peripheral Blood Hematopoietic Progenitor Cells
CLICK HERE to view the summary and slides.
Chair: Dr. Shirley Bartido, QA Manager, Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center
Dr. Bruce Levine, Associate Professor, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine
Dr. Isabelle Rivière, Director, Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center
CLICK HERE to learn more and register.
Vancouver, Canada (Wednesday, January 19, 2011) In keeping with its commitment to connect industry, regulatory experts, therapeutic societies and translational centers to advance emerging cellular therapies, ISCT announces its first commercial development focus group addressing Cell Therapies for Peripheral Vascular Disease (PVD)
VIEW PRESS RELEASE
Lab Practices Committee releases survey on CD34 usage.
CLICK HERE to take the survey!
Registration now open for the 17th ISCT Meeting.
Abstract submission deadline: January 31, 2011
Early registration deadline: February 4, 2011
CLICK HERE to learn more
to learn more
Included are presentations from EMA and the Paul-Ehrlich-Institut. CLICK HERE
The results from the survey to assess the status of ISBT 128 implementation in cellular therapy are now available. CLICK HERE for the results.
October 27, 2010
This survey is a follow up to a similar survey in 2004. The Lab Practices Committee is gathering some of the same information, with some additional details, to see how facilities have expanded, changed, qualified and perfected their cleaning protocols.
Vancouver, Canada (Monday, August 16, 2010) — Many companies in the cell therapy regenerative medicine market including Roche, Genzyme, Athersys, Miltenyi Biotec, Hospira, Lonza and Life Technologies will join ISCT to launch a series of new initiatives that will create greater strategic alignment within the industry and drive late stage clinical development.
Announcing the ISCT Members-Only Workshop on September 21, 2010 in New York City. Are you new to Quality Assurance or have you just been assigned to write or update your facilities Quality Plan?
The Lab Practices Committee is currently looking for new members.
ISCT Laboratory Committee has provided template Validation SOPs for the CT community.
is soliciting proposals for a Cell Characterization core. The budget is up to $500K/yr for 2 years. Proposals are due June 15, 2010.
Baxter has released a letter to customers.
The 9th Cell Therapy Liaison Meeting focused on the topic of Information Technology in Cellular Therapy.